AGP Picks
View all

Good Morning! Latin America
Provided by AGP

Good Morning! Latin America: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 18, 2026

Announcement of Results of the Tender Offer for Any and All 2029 Notes by Movida Europe S.A.
May 18, 2026

Announcement of Results of the Tender Offer for Any and All 2029 Notes by Movida Europe S.A.

Indeterminate GlobeNewswire
Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications
May 18, 2026

Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications

Indeterminate GlobeNewswire
Bitget Hosts ‘Summer Camp’ for Global Leaders and KOLs in South East Asia
May 18, 2026

Bitget Hosts ‘Summer Camp’ for Global Leaders and KOLs in South East Asia

Indeterminate GlobeNewswire
Critical Metals Signs Definitive Agreement to Acquire European Lithium
May 18, 2026

Critical Metals Signs Definitive Agreement to Acquire European Lithium

Indeterminate GlobeNewswire
Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards
May 18, 2026

Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards

Indeterminate GlobeNewswire
Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
May 18, 2026

Kyverna Therapeutics Names Greg Martini as Chief Financial Officer

Indeterminate GlobeNewswire
Aeries Technology Launches A1 GCC, an Agentic AI-Driven Operations Platform for Global Capability Centers
May 18, 2026

Aeries Technology Launches A1 GCC, an Agentic AI-Driven Operations Platform for Global Capability Centers

Indeterminate GlobeNewswire
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 18, 2026

CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates
May 18, 2026

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Bitget Enters Mexico Market With SAT and UIF Registration
May 18, 2026

Bitget Enters Mexico Market With SAT and UIF Registration

Indeterminate GlobeNewswire
AFX Launches Sovereign Layer 1, Providing an Optimized Execution Environment for On-chain Perp DEXes
May 18, 2026

AFX Launches Sovereign Layer 1, Providing an Optimized Execution Environment for On-chain Perp DEXes

Indeterminate GlobeNewswire
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
May 18, 2026

Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board

Indeterminate GlobeNewswire
Bitget IPO Prime Taps Into $4T AI Opportunity With OpenAI
May 18, 2026

Bitget IPO Prime Taps Into $4T AI Opportunity With OpenAI

Indeterminate GlobeNewswire
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 18, 2026

Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202

Indeterminate GlobeNewswire
Cytovation to Evaluate Getacatetide (CY-101) in Combination with Checkpoint Inhibitor Tislelizumab in Colorectal Cancer
May 18, 2026

Cytovation to Evaluate Getacatetide (CY-101) in Combination with Checkpoint Inhibitor Tislelizumab in Colorectal Cancer

Indeterminate GlobeNewswire

Share this page:

Sign up for:

Good Morning! Latin America

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.